Pemphigus News and Research

RSS
Pemphigus is the term used to describe a group of autoimmune diseases that cause the skin and mucous membranes to become blistered. The conditions may therefore affect areas of the body such as the mouth, eyes, nose, throat, or genitals. In some cases, these diseases may be fatal if they are left untreated.
New, nanotech-based strategy could enable safe, long-term treatment for autoimmune diseases

New, nanotech-based strategy could enable safe, long-term treatment for autoimmune diseases

NIH begins clinical trial to assess extra COVID-19 vaccine dose in people with autoimmune disease

NIH begins clinical trial to assess extra COVID-19 vaccine dose in people with autoimmune disease

Drug regimen for lymphoma and RA more likely to put patients with pemphigus into remission

Drug regimen for lymphoma and RA more likely to put patients with pemphigus into remission

CAR-T cell therapy could be on the horizon for patients with lupus

CAR-T cell therapy could be on the horizon for patients with lupus

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Two new studies find potential genetic cause and new treatment method for autoimmune diseases

Two new studies find potential genetic cause and new treatment method for autoimmune diseases

New strategy treats fatal autoimmune disease without outward off-target effects

New strategy treats fatal autoimmune disease without outward off-target effects

Researchers discover new details of how autoantibodies destroy healthy cells in skin

Researchers discover new details of how autoantibodies destroy healthy cells in skin

Lyfebulb, Immune collaborate to increase awareness of bullous pemphigoid

Lyfebulb, Immune collaborate to increase awareness of bullous pemphigoid

Researchers find shared genetic link in autoimmune response among PV patients

Researchers find shared genetic link in autoimmune response among PV patients

Therapeutic targets for pemphigus vulgaris discovered

Therapeutic targets for pemphigus vulgaris discovered

Rockefeller University funds clinical, translational pilot studies

Rockefeller University funds clinical, translational pilot studies

Rituximab used to treat skin disorders

Rituximab used to treat skin disorders

Dermatology's role in advancing the science of wound care

Dermatology's role in advancing the science of wound care

Severe reduction of Treg cells may be involved in development of pemphigus vulgaris

Severe reduction of Treg cells may be involved in development of pemphigus vulgaris

New insights into Pemphigus

New insights into Pemphigus

Results from study of Rituxan in rheumatoid arthritis show promise

Results from study of Rituxan in rheumatoid arthritis show promise

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.